These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 14518575)
1. Demystifying FluMist, a new intranasal, live influenza vaccine. Mossad SB Cleve Clin J Med; 2003 Sep; 70(9):801-6. PubMed ID: 14518575 [TBL] [Abstract][Full Text] [Related]
2. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
3. Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. Jackson LA; Holmes SJ; Mendelman PM; Huggins L; Cho I; Rhorer J Vaccine; 1999 Apr; 17(15-16):1905-9. PubMed ID: 10217588 [TBL] [Abstract][Full Text] [Related]
5. Intranasal flu vaccine available this season. Piascik P J Am Pharm Assoc (2003); 2003; 43(6):728-30. PubMed ID: 14717271 [TBL] [Abstract][Full Text] [Related]
6. FluMist: an intranasal live influenza vaccine. Med Lett Drugs Ther; 2003 Aug; 45(1163):65-6. PubMed ID: 12915803 [No Abstract] [Full Text] [Related]
7. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [TBL] [Abstract][Full Text] [Related]
8. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice. Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209 [TBL] [Abstract][Full Text] [Related]
9. Role of influenza vaccine for healthy children in the US. Block SL Paediatr Drugs; 2004; 6(4):199-209. PubMed ID: 15339199 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B; Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647 [TBL] [Abstract][Full Text] [Related]
12. Live attenuated influenza vaccine for children. Drug Ther Bull; 2017 Oct; 55(10):114-117. PubMed ID: 29021248 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. Belshe RB; Gruber WC; Mendelman PM; Cho I; Reisinger K; Block SL; Wittes J; Iacuzio D; Piedra P; Treanor J; King J; Kotloff K; Bernstein DI; Hayden FG; Zangwill K; Yan L; Wolff M J Pediatr; 2000 Feb; 136(2):168-75. PubMed ID: 10657821 [TBL] [Abstract][Full Text] [Related]
14. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468 [TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193 [TBL] [Abstract][Full Text] [Related]
16. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children. Coelingh K; Olajide IR; MacDonald P; Yogev R Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891 [TBL] [Abstract][Full Text] [Related]
19. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age. Mallory RM; Yi T; Ambrose CS Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761 [TBL] [Abstract][Full Text] [Related]
20. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]